Jennifer Larson | executive |
Steven Hoerter | executive |
Daniel Martin | executive |
Margarida Duarte | executive |
Matthew Sherman | executive |
Thomas Kelly | executive |
Tyler Van Buren | analyst |
Eun Yang | analyst |
Michael Schmidt | analyst |
Christopher Raymond | analyst |
Andrew Berens | analyst |
Bradley Canino | analyst |
Reni Benjamin | analyst |
Shea Feeney | analyst |
Good morning, everyone, and welcome to the Deciphera Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Jen Larson, Senior Vice President of Finance and Investor Relations. Jen?
Thank you, operator.